Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study

Medicine

Prensa/medios de comunicación: Research

Períodosep. 11 2023

Cobertura de los medios

1

Cobertura de los medios

  • NombreSona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study
    Nombre/canal del medio de comunicaciónBioSpace
    País/TerritorioUnited States
    Fecha9/11/23
    PersonasCarman Anthony Giacomantonio
Ver todos 1
Ver menos